Viewing Study NCT01253434


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2025-12-27 @ 11:49 PM
Study NCT ID: NCT01253434
Status: COMPLETED
Last Update Posted: 2013-05-14
First Post: 2010-11-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: E2022 Patch Formulation Single Dose Phase I Study
Sponsor: Eisai Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module